Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2008
06/25/2008EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule
06/25/2008EP1935417A1 Composition for use in prevention of hypoglycemic condition
06/25/2008EP1935414A2 Carbonic anhydrase activators for enhancig learning and memory
06/25/2008EP1933858A1 A medical composition for treating wounds
06/25/2008EP1933831A2 Modulators of atp-binding cassette transporters
06/25/2008EP1933821A1 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
06/25/2008EP1675850B1 Quinoline compounds and their uses
06/25/2008EP1492534B1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
06/25/2008EP1485345B1 Urokinase inhibitors, production and use thereof
06/25/2008EP1458393B1 Substituted diketopiperazines as oxytocin antagonists
06/25/2008EP1395604B1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives
06/25/2008EP1328271B1 Treatment of neurological and neuropsychological disorders
06/25/2008EP1261320B1 Micellar pharmaceutical compositions for buccal and pulmonary application
06/25/2008EP1200127B1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation
06/25/2008EP1173180B1 Camptothecin analogs and methods of preparation thereof
06/25/2008EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
06/25/2008EP1041991B1 Non antibacterial tetracyclins for the treatment of multiple sclerosis
06/25/2008EP0988051B1 Lyme combination compositions and uses
06/25/2008EP0986382B1 Raf kinase inhibitors
06/25/2008EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes.
06/25/2008CN101205251A Chinese south China sea signal taro snail nerve toxin gene Lt3.2 and uses thereof
06/25/2008CN101204560A Pharmaceutical capsules for sunstroke
06/25/2008CN101204556A Ointment for hypothyroid cystic hyperplasia and preparing method thereof
06/25/2008CN101204537A Chinese traditional medicine composite for reducing spitting, dispelling wind, and relieving convulsion and preparation method thereof
06/25/2008CN101204415A Patch for treating sunstroke
06/25/2008CN101204202A Ruminant humus pellet feed
06/25/2008CN100397081C Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy
06/25/2008CN100396769C Novel probiotics for pet food applications
06/25/2008CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/25/2008CN100396676C Synthesis of piperidine and piperazine compounds as CCR5 antagonists
06/25/2008CN100396675C Prodrugs of proton pump inhibitors
06/25/2008CN100396669C Production of pyriphenanthrenone as anti-fibrosis medicine
06/25/2008CN100396668C Non-imidazole aryloxypiperidines
06/25/2008CN100396327C Use of composition in preparing antifatigue medicament
06/25/2008CN100396283C Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
06/24/2008US7392233 Image searching system, image searching method, and a recording medium storing an image searching program
06/24/2008US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
06/24/2008US7390905 Tachykinin receptor antagonists for use treating e.g. emesis, depression, urinary disorder
06/24/2008US7390898 Cytotoxic agents containing novel potent taxanes and their therapeutic use
06/24/2008US7390896 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide
06/24/2008US7390890 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases
06/24/2008US7390822 Delta-2 opioid receptor agonists; protecting cardiac and cerebral organs
06/24/2008US7390821 Administering nicotinic acetylcholine receptor antagonist; ocular diseases; monoclonal antibodies
06/24/2008US7390815 Pyrazole compounds useful as protein kinase inhibitors
06/24/2008US7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
06/24/2008US7390805 Tyrosine kinase inhibitors; antiproliferative agents; antitumor agents
06/24/2008US7390802 Substituted lactams as inhibitors of Aβ protein production
06/24/2008US7390797 Fused indazole compounds
06/24/2008US7390785 Amino acid sequences; from venom of snails; analgesics
06/24/2008US7390668 Halogenated xanthan compound
06/24/2008US7390625 Apoptosis-associated protein and use thereof
06/19/2008WO2008073961A2 Compounds and methods for modulating the silencing of a polynucleotide of interest
06/19/2008WO2008073774A1 Systems and methods for detecting infrared emitting composites and medical applications therefor
06/19/2008WO2008073331A2 Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
06/19/2008WO2008073257A1 Use of prodrugs of gaba analogs for treating diseases
06/19/2008WO2008072778A1 Therapeutic agent for urinary tract disease
06/19/2008WO2008072726A1 1-phenyl 1-thio-d-glucitol derivative
06/19/2008WO2008072723A1 ANTI-Claudin-3 MONOCLONAL ANTIBODY, AND TREATMENT AND DIAGNOSIS OF CANCER USING THE SAME
06/19/2008WO2008072703A1 Biphenylamide derivative
06/19/2008WO2008072682A1 Imidazo[1,2-b]pyridazine derivative
06/19/2008WO2008072663A1 Composition for amelioration/prevention of adverse side effect in steroid therapy
06/19/2008WO2008072658A1 2-phenylnicotinic acid derivative
06/19/2008WO2008072655A1 Imidazothiazole derivatives
06/19/2008WO2008072634A1 Fused heterocyclic compound
06/19/2008WO2008072591A1 Iron metabolism-improving agent
06/19/2008WO2008072360A1 Catechin composition and method for producing the same
06/19/2008WO2008071934A1 Treatment of cachexia
06/19/2008WO2008071173A1 Preparations for inhibiting prostaglandin e2 synthesis
06/19/2008WO2008071075A1 A process for preparation of extract of broussonetia papyritera and the use thereof in manufacture of a medicament
06/19/2008US20080147131 Method for muscle delivery of drugs, nucleic acids and other compounds
06/19/2008US20080146836 New Aminopropylphosphinic acids
06/19/2008US20080146821 Internal 1,15-Lactones Of Fluprostenol And Related Prostaglandin F2a Analogs And Their Use In The Treatment Of Glaucoma And Intraocular Hypertension
06/19/2008US20080146818 Dipeptidylpeptidase IV (DPP-IV) inhibitory activity; (2S,4S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)); diabetes
06/19/2008US20080146785 Antibody against tumor specific antigen as target
06/19/2008US20080146678 O/W Emulsion Composition
06/19/2008US20080146661 Substituted arylamino -1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1H-indenes as potassium channel modulators
06/19/2008US20080146660 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired
06/19/2008US20080146647 Acetylene derivatives having mglur 5 antagonistic activity
06/19/2008US20080146639 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment
06/19/2008US20080146633 Compositions for skin lightening and toning down pigment disorders, comprising creatinine and/or creatinine derivatives as active substances
06/19/2008US20080146631 Peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis
06/19/2008US20080146628 Lowering prolactin serum level; attention deficit hyperactivity disorder (ADHD)
06/19/2008US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain.
06/19/2008US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof
06/19/2008US20080146592 Method of Treating Preeclampsia Employing Metolazone
06/19/2008US20080146578 Indolylmaleimide derivatives
06/19/2008US20080146572 N-sulfonylurea apoptosis promoters
06/19/2008US20080146568 Spiro-piperidine derivatives
06/19/2008US20080146546 Bicyclic and Tricyclic Heteroaromatic Compounds
06/19/2008US20080146530 Re-epithelializing pharmaceutical compositions comprising xanthan gum
06/19/2008US20080146528 stilbene phosphate derivatives; anticarcinogenic agents; bactericide, fungicide; veterinary medicine
06/19/2008US20080146522 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules
06/19/2008US20080146519 IL-14alpha RNA inhibitors and antibodies to IL-14alpha for treatment of autoimmune diseases and lymphomas
06/19/2008US20080146518 Cationic Lipids for the Transfection of Nucleic Acids
06/19/2008US20080146511 method of peptides, peptides, method and kit for the identification of infections by Mycobacterium leprae, as well as to pharmaceutical and immunological compositions containing as active principle(s), peptide(s) of Mycobacterium leprae or sequences functionally similar
06/19/2008US20080146510 For suppressing cell proliferation/tumor growth or modulating immune system by transformation of T-lymphocytes or enhancement of natural killer cells
06/19/2008US20080146508 Soluble cyclic analogues of beta amyloid peptide
06/19/2008US20080146506 Methods of Suppressing Microglial Activation
06/19/2008US20080146505 47 Human Secreted Proteins
06/19/2008US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins